1. 87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience. (December 2022) Authors: Zhang, S.H.; Cartwright, E.; Mullings, S.; Ferro Lopez, L.F.; Cunningham, D.; Chau, I.; Starling, N.; Popat, S.; O'Brien, M.E.R.; Bhosle, J.; Minchom, A.R.; Davidson, M.; Tokaca, N.; Lalondrelle, S.; Pickering, L.M.; Furness, A.; Turajlic, S.; Larkin, J.; José, R.; Young, K. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗